-
1
-
-
79952232216
-
Global cancer statistics
-
21296855 10.3322/caac.20107
-
Jemal A, Bray F, Center MM, Ferlay J, Ward E et al (2011) Global cancer statistics. CA Cancer J Clin 61:69-90
-
(2011)
CA Cancer J Clin
, vol.61
, pp. 69-90
-
-
Jemal, A.1
Bray, F.2
Center, M.M.3
Ferlay, J.4
Ward, E.5
-
2
-
-
0035888074
-
Estimating the world cancer burden: Globocan 2000
-
DOI 10.1002/ijc.1440
-
Parkin DM, Bray F, Ferlay J, Pisani P (2001) Estimating the world cancer burden: Globocan 2000. Int J Cancer 94:153-156 (Pubitemid 32911406)
-
(2001)
International Journal of Cancer
, vol.94
, Issue.2
, pp. 153-156
-
-
Maxwell Parkin, D.1
Bray, F.2
Ferlay, J.3
Pisani, P.4
-
3
-
-
63749101977
-
-
International Agency for Research on Cancer
-
Boyle P, Levin B (eds) (2008) World Cancer Report 2008. International Agency for Research on Cancer, pp 374-375
-
(2008)
World Cancer Report 2008
, pp. 374-375
-
-
Boyle, P.1
Levin, B.2
-
4
-
-
0033281771
-
How many more breast cancer predisposition genes are there?
-
DOI 10.1186/bcr6
-
Easton DF (1999) How many more breast cancer predisposition genes are there? Breast Cancer Res 1:14-17 (Pubitemid 32223529)
-
(1999)
Breast Cancer Research
, vol.1
, Issue.1
, pp. 14-17
-
-
Easton, D.F.1
-
5
-
-
8144225291
-
Association studies for finding cancer-susceptibility genetic variants
-
DOI 10.1038/nrc1476
-
Pharoah PD, Dunning AM, Ponder BA, Easton DF (2004) Association studies for finding cancer-susceptibility genetic variants. Nat Rev Cancer 4:850-860 (Pubitemid 39472952)
-
(2004)
Nature Reviews Cancer
, vol.4
, Issue.11
, pp. 850-860
-
-
Pharoah, P.D.P.1
Dunning, A.M.2
Ponder, B.A.J.3
Easton, D.F.4
-
6
-
-
33749002551
-
Models of genetic susceptibility to breast cancer
-
DOI 10.1038/sj.onc.1209879, PII 1209879
-
Antoniou AC, Easton DF (2006) Models of genetic susceptibility to breast cancer. Oncogene 25:5898-5905 (Pubitemid 44453445)
-
(2006)
Oncogene
, vol.25
, Issue.43
, pp. 5898-5905
-
-
Antoniou, A.C.1
Easton, D.F.2
-
7
-
-
2142758177
-
P53 is a tumor suppressor gene
-
Levine AJ, Finlay CA, Hinds PW (2004) P53 is a tumor suppressor gene. CELL 116: S67-69, 61 p following S69
-
(2004)
CELL
, vol.116
-
-
Levine, A.J.1
-
8
-
-
0037372005
-
The codon 72 polymorphic variants of p53 have markedly different apoptotic potential
-
DOI 10.1038/ng1093
-
Dumont P, Leu JI, Della Pietra AC III, George DL, Murphy M (2003) The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 33:357-365 (Pubitemid 36278852)
-
(2003)
Nature Genetics
, vol.33
, Issue.3
, pp. 357-365
-
-
Dumont, P.1
Leu, J.I.-J.2
Della Pietra III, A.C.3
George, D.L.4
Murphy, M.5
-
9
-
-
33646807832
-
The P53 pathway: What questions remain to be explored?
-
16557269 10.1038/sj.cdd.4401910 1:CAS:528:DC%2BD28Xks1Ortbw%3D
-
Levine AJ, Hu W, Feng Z (2006) The P53 pathway: what questions remain to be explored? Cell Death Differ 13:1027-1036
-
(2006)
Cell Death Differ
, vol.13
, pp. 1027-1036
-
-
Levine, A.J.1
Hu, W.2
Feng, Z.3
-
10
-
-
74849083374
-
Differential effects of MDM2 SNP309 polymorphism on breast cancer risk along with race: A meta-analysis
-
19590949 10.1007/s10549-009-0467-1
-
Economopoulos KP, Sergentanis TN (2010) Differential effects of MDM2 SNP309 polymorphism on breast cancer risk along with race: a meta-analysis. Breast Cancer Res Treat 120:211-216
-
(2010)
Breast Cancer Res Treat
, vol.120
, pp. 211-216
-
-
Economopoulos, K.P.1
Sergentanis, T.N.2
-
11
-
-
77950689604
-
P53 codon 72 polymorphism contributes to breast cancer risk: A meta-analysis based on 39 case-control studies
-
19629678 10.1007/s10549-009-0480-4 1:CAS:528:DC%2BC3cXjtlahtb0%3D
-
Zhang Z, Wang M, Wu D, Tong N, Tian Y (2010) P53 codon 72 polymorphism contributes to breast cancer risk: a meta-analysis based on 39 case-control studies. Breast Cancer Res Treat 120:509-517
-
(2010)
Breast Cancer Res Treat
, vol.120
, pp. 509-517
-
-
Zhang, Z.1
Wang, M.2
Wu, D.3
Tong, N.4
Tian, Y.5
-
12
-
-
78651078681
-
No significant association between the TP53 codon 72 polymorphism and breast cancer risk: A meta-analysis of 21 studies involving 24,063 subjects
-
20496166 10.1007/s10549-010-0920-1
-
Ma Y, Yang J, Liu Z, Zhang P, Yang Z et al (2011) No significant association between the TP53 codon 72 polymorphism and breast cancer risk: a meta-analysis of 21 studies involving 24,063 subjects. Breast Cancer Res Treat 125:201-205
-
(2011)
Breast Cancer Res Treat
, vol.125
, pp. 201-205
-
-
Ma, Y.1
Yang, J.2
Liu, Z.3
Zhang, P.4
Yang, Z.5
-
13
-
-
79957442050
-
MDM2 SNP309, gene-gene interaction, and tumor susceptibility: An updated meta-analysis
-
21619694 10.1186/1471-2407-11-208 1:CAS:528:DC%2BC3MXntVWru70%3D
-
Wan Y, Wu W, Yin Z, Guan P, Zhou B (2011) MDM2 SNP309, gene-gene interaction, and tumor susceptibility: an updated meta-analysis. BMC Cancer 11:208
-
(2011)
BMC Cancer
, vol.11
, pp. 208
-
-
Wan, Y.1
Wu, W.2
Yin, Z.3
Guan, P.4
Zhou, B.5
-
14
-
-
35148876519
-
Do MDM2 SNP309 and TP53 R72P interact in breast cancer susceptibility? A large pooled series from the breast cancer association consortium
-
DOI 10.1158/0008-5472.CAN-07-0738
-
Schmidt MK, Reincke S, Broeks A, Braaf LM, Hogervorst FB et al (2007) Do MDM2 SNP309 and TP53 R72P interact in breast cancer susceptibility? A large pooled series from the breast cancer association consortium. Cancer Res 67:9584-9590 (Pubitemid 47535950)
-
(2007)
Cancer Research
, vol.67
, Issue.19
, pp. 9584-9590
-
-
Schmidt, M.K.1
Reincke, S.2
Broeks, A.3
Braaf, L.M.4
Hogervorst, F.B.L.5
Tollenaar, R.A.E.M.6
Johnson, N.7
Fletcher, O.8
Peto, J.9
Tommiska, J.10
Blomqvist, C.11
Nevanlinna, H.A.12
Healey, C.S.13
Dunning, A.M.14
Pharoah, P.D.P.15
Easton, D.F.16
Dork, T.17
Van't Veer, L.J.18
-
15
-
-
34249982811
-
The p53 Arg72Pro and MDM2 -309 polymorphisms and risk of breast cancer in the nurses' health studies
-
DOI 10.1007/s10552-007-9004-x
-
Cox DG, Deer D, Guo Q, Tworoger SS, Hankinson SE et al (2007) The p53 Arg72Pro and MDM2-309 polymorphisms and risk of breast cancer in the nurses' health studies. Cancer Causes Control 18:621-625 (Pubitemid 46883679)
-
(2007)
Cancer Causes and Control
, vol.18
, Issue.6
, pp. 621-625
-
-
Cox, D.G.1
Deer, D.2
Guo, Q.3
Tworoger, S.S.4
Hankinson, S.E.5
Hunter, D.J.6
De Vivo, I.7
-
16
-
-
36549070713
-
Association of Polymorphism in MDM-2 and p53 Genes with Breast Cancer Risk in Indian Women
-
DOI 10.1016/j.annepidem.2007.06.006, PII S1047279707002517
-
Singh V, Rastogi N, Mathur N, Singh K, Singh MP (2008) Association of polymorphism in MDM-2 and p53 genes with breast cancer risk in Indian women. Ann Epidemiol 18:48-57 (Pubitemid 350184342)
-
(2008)
Annals of Epidemiology
, vol.18
, Issue.1
, pp. 48-57
-
-
Singh, V.1
Rastogi, N.2
Mathur, N.3
Singh, K.4
Singh, M.P.5
-
17
-
-
70349316753
-
The significance of MDM2 SNP309 and p53 Arg72Pro in young women with breast cancer
-
19639206
-
Lang A, Palmeback Wegman P, Wingren S (2009) The significance of MDM2 SNP309 and p53 Arg72Pro in young women with breast cancer. Oncol Rep 22:575-579
-
(2009)
Oncol Rep
, vol.22
, pp. 575-579
-
-
Lang, A.1
Palmeback Wegman, P.2
Wingren, S.3
-
18
-
-
77954578718
-
Combined effects of single nucleotide polymorphisms TP53 R72P and MDM2 SNP309, and p53 expression on survival of breast cancer patients
-
20021639 10.1186/bcr2460
-
Schmidt MK, Tommiska J, Broeks A, van Leeuwen FE, Van't Veer LJ et al (2009) Combined effects of single nucleotide polymorphisms TP53 R72P and MDM2 SNP309, and p53 expression on survival of breast cancer patients. Breast Cancer Res 11:R89
-
(2009)
Breast Cancer Res
, vol.11
, pp. 89
-
-
Schmidt, M.K.1
Tommiska, J.2
Broeks, A.3
Van Leeuwen, F.E.4
Van'T Veer, L.J.5
-
19
-
-
79954536556
-
Involvement of p53 R72P polymorphism in the association of MDM2-SNP309 with breast cancer
-
21479369 1:CAS:528:DC%2BC3MXnsVWhurk%3D
-
Leu JD, Wang CY, Tsai HY, Lin IF, Chen RC et al (2011) Involvement of p53 R72P polymorphism in the association of MDM2-SNP309 with breast cancer. Oncol Rep 25:1755-1763
-
(2011)
Oncol Rep
, vol.25
, pp. 1755-1763
-
-
Leu, J.D.1
Wang, C.Y.2
Tsai, H.Y.3
Lin, I.F.4
Chen, R.C.5
-
20
-
-
82255175076
-
Combined effects of MDM2 SNP309 and TP53 R72P polymorphisms, and soy isoflavones on breast cancer risk among Chinese women in Singapore
-
21833626 10.1007/s10549-011-1680-2 1:CAS:528:DC%2BC3MXhsFWjtbrJ
-
Koh WP, Van Den Berg D, Jin A, Wang R, Yuan JM et al (2011) Combined effects of MDM2 SNP309 and TP53 R72P polymorphisms, and soy isoflavones on breast cancer risk among Chinese women in Singapore. Breast Cancer Res Treat 130:1011-1109
-
(2011)
Breast Cancer Res Treat
, vol.130
, pp. 1011-1109
-
-
Koh, W.P.1
Van Den Berg, D.2
Jin, A.3
Wang, R.4
Yuan, J.M.5
-
21
-
-
84860253710
-
A single-nucleotide polymorphism in the TP53 and MDM-2 gene modifies breast cancer risk in an ethnic Arab population
-
Alshatwi AA, Hasan TN, Shafi G, Alsaif MA, Al-Hazzani AA, et al (2012) A single-nucleotide polymorphism in the TP53 and MDM-2 gene modifies breast cancer risk in an ethnic Arab population. Fundam Clin Pharmacol 26:438-443
-
(2012)
Fundam Clin Pharmacol
, vol.26
, pp. 438-443
-
-
Alshatwi, A.A.1
-
22
-
-
0345196595
-
Power and sample size calculations in case-control studies of gene- environment interactions: Comments on different approaches
-
Garcia-Closas M, Lubin JH (1999) Power and sample size calculations in case-control studies of gene-environment interactions: comments on different approaches. Am J Epidemiol 149:689-692 (Pubitemid 29180776)
-
(1999)
American Journal of Epidemiology
, vol.149
, Issue.8
, pp. 689-692
-
-
Garcia-Closas, M.1
Lubin, J.H.2
-
23
-
-
0030922816
-
Bias in meta-analysis detected by a simple, graphical test
-
Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-634 (Pubitemid 27387172)
-
(1997)
British Medical Journal
, vol.315
, Issue.7109
, pp. 629-634
-
-
Egger, M.1
Smith, G.D.2
Schneider, M.3
Minder, C.4
-
24
-
-
0029888758
-
P53 polymorphisms and haplotypes in breast cancer
-
DOI 10.1093/carcin/17.6.1313
-
Sjalander A, Birgander R, Hallmans G, Cajander S, Lenner P et al (1996) p53 Polymorphisms and haplotypes in breast cancer. Carcinogenesis 17:1313-1316 (Pubitemid 26196343)
-
(1996)
Carcinogenesis
, vol.17
, Issue.6
, pp. 1313-1316
-
-
Sjalander, A.1
Birgander, R.2
Hallmans, G.3
Cajander, S.4
Leenner, P.5
Athlin, L.6
Beckman, G.7
Beckman, L.8
-
25
-
-
16944365232
-
P53 Haplotype determination in breast cancer
-
Weston A, Pan CF, Ksieski HB, Wallenstein S, Berkowitz GS et al (1997) p53 Haplotype determination in breast cancer. Cancer Epidemiol Biomarkers Prev 6:105-112 (Pubitemid 27069203)
-
(1997)
Cancer Epidemiology Biomarkers and Prevention
, vol.6
, Issue.2
, pp. 105-112
-
-
Weston, A.1
Pan, C.-F.2
Ksieski, H.B.3
Wallenstein, S.4
Berkowitz, G.S.5
Tartter, P.I.6
Bleiweiss, I.J.7
Brower, S.T.8
Senie, R.T.9
Wolff, M.S.10
-
26
-
-
0037114777
-
P53 Codon 72 polymorphism (C/G) and the risk of human papillomavirus-associated carcinomas in China
-
DOI 10.1002/cncr.11008
-
Li T, Lu ZM, Guo M, Wu QJ, Chen KN et al (2002) p53 Codon 72 polymorphism (C/G) and the risk of human papillomavirus-associated carcinomas in China. Cancer 95:2571-2576 (Pubitemid 35424044)
-
(2002)
Cancer
, vol.95
, Issue.12
, pp. 2571-2576
-
-
Li, T.1
Lu, Z.-M.2
Guo, M.3
Wu, Q.-J.4
Chen, K.-N.5
Xing, H.-P.6
Mei, Q.7
Ke, Y.8
-
27
-
-
0036260271
-
Intron 3 16 bp duplication polymorphism of p53 is associated with an increased risk for breast cancer by the age of 50 years
-
DOI 10.1097/00008571-200204000-00012
-
Wang-Gohrke S, Becher H, Kreienberg R, Runnebaum IB, Chang-Claude J (2002) Intron 3 16 bp duplication polymorphism of p53 is associated with an increased risk for breast cancer by the age of 50 years. Pharmacogenetics 12:269-272 (Pubitemid 34596792)
-
(2002)
Pharmacogenetics
, vol.12
, Issue.3
, pp. 269-272
-
-
Wang-Gohrke, S.1
Becher, H.2
Kreienberg, R.3
Runnebaum, I.B.4
Chang-Claude, J.5
-
28
-
-
0642314312
-
P53 Codon 72 polymorphism in breast cancer
-
12684648 1:CAS:528:DC%2BD3sXjsVOltLg%3D
-
Buyru N, Tigli H, Dalay N (2003) p53 Codon 72 polymorphism in breast cancer. Oncol Rep 10:711-714
-
(2003)
Oncol Rep
, vol.10
, pp. 711-714
-
-
Buyru, N.1
Tigli, H.2
Dalay, N.3
-
29
-
-
1542546270
-
Association of p53 codon Arg72Pro and p73 G4C14-to-A4T14 at exon 2 genetic polymorphisms with the risk of Japanese breast cancer
-
14634508 10.1007/BF02967650
-
Huang XE, Hamajima N, Katsuda N, Matsuo K, Hirose K et al (2003) Association of p53 codon Arg72Pro and p73 G4C14-to-A4T14 at exon 2 genetic polymorphisms with the risk of Japanese breast cancer. Breast Cancer 10:307-311
-
(2003)
Breast Cancer
, vol.10
, pp. 307-311
-
-
Huang, X.E.1
Hamajima, N.2
Katsuda, N.3
Matsuo, K.4
Hirose, K.5
-
30
-
-
0141616560
-
Polymorphism of the p53 codon 72 arg/pro and the risk of HPV type 16/18-associated cervical and oral cancer in India
-
DOI 10.1023/A:1025546610920
-
Katiyar S, Thelma BK, Murthy NS, Hedau S, Jain N et al (2003) Polymorphism of the p53 codon 72 Arg/Pro and the risk of HPV type 16/18-associated cervical and oral cancer in India. Mol Cell Biochem 252:117-124 (Pubitemid 37220740)
-
(2003)
Molecular and Cellular Biochemistry
, vol.252
, Issue.1-2
, pp. 117-124
-
-
Katiyar, S.1
Thelma, B.K.2
Murthy, N.S.3
Hedau, S.4
Jain, N.5
Gopalkrishna, V.6
Akhtar Husain, S.7
Das, B.C.8
-
31
-
-
10744231895
-
No Evidence of Correlation between p53 Codon 72 Polymorphism and Risk of Bladder or Breast Carcinoma in Tunisian Patients
-
DOI 10.1196/annals.1299.137
-
Mabrouk I, Baccouche S, El-Abed R, Mokdad-Gargouri R, Mosbah A et al (2003) No evidence of correlation between p53 codon 72 polymorphism and risk of bladder or breast carcinoma in Tunisian patients. Ann N Y Acad Sci 1010:764-770 (Pubitemid 38265078)
-
(2003)
Annals of the New York Academy of Sciences
, vol.1010
, pp. 764-770
-
-
Mabrouk, I.1
Baccouche, S.2
El-Abed, R.3
Mokdad-Gargouri, R.4
Mosbah, A.5
Said, S.6
Daoud, J.7
Frikha, M.8
Jlidi, R.9
Gargouri, A.10
-
32
-
-
17444387812
-
The association of p53 mutations and p53 codon 72, Her 2 codon 655 and MTHFR C677T polymorphisms with breast cancer in Northern Greece
-
DOI 10.1016/j.canlet.2004.11.025
-
Kalemi TG, Lambropoulos AF, Gueorguiev M, Chrisafi S, Papazisis KT et al (2005) The association of p53 mutations and p53 codon 72, Her 2 codon 655 and MTHFR C677T polymorphisms with breast cancer in Northern Greece. Cancer Lett 222:57-65 (Pubitemid 40544847)
-
(2005)
Cancer Letters
, vol.222
, Issue.1
, pp. 57-65
-
-
Kalemi, T.G.1
Lambropoulos, A.F.2
Gueorguiev, M.3
Chrisafi, S.4
Papazisis, K.T.5
Kotsis, A.6
-
33
-
-
22344450943
-
Breast cancer patients with p53 pro72 homozygous genotype have a poorer survival
-
DOI 10.1158/1078-0432.CCR-05-0173
-
Tommiska J, Eerola H, Heinonen M, Salonen L, Kaare M et al (2005) Breast cancer patients with p53 Pro72 homozygous genotype have a poorer survival. Clin Cancer Res 11:5098-5103 (Pubitemid 41003693)
-
(2005)
Clinical Cancer Research
, vol.11
, Issue.14
, pp. 5098-5103
-
-
Tommiska, J.1
Eerola, H.2
Heinonen, M.3
Salonen, L.4
Kaare, M.5
Tallila, J.6
Ristimaki, A.7
Von Smitten, K.8
Aittomaki, K.9
Heikkila, P.10
Blomqvist, C.11
Nevanlinna, H.12
-
34
-
-
33745783716
-
Association of breast cancer outcome with status of p53 and MDM2 SNP309
-
DOI 10.1093/jnci/djj245
-
Boersma BJ, Howe TM, Goodman JE, Yfantis HG, Lee DH et al (2006) Association of breast cancer outcome with status of p53 and MDM2 SNP309. J Natl Cancer Inst 98:911-919 (Pubitemid 44018921)
-
(2006)
Journal of the National Cancer Institute
, vol.98
, Issue.13
, pp. 911-919
-
-
Boersma, B.J.1
Howe, T.M.2
Goodman, J.E.3
Yfantis, H.G.4
Lee, D.H.5
Chanock, S.J.6
Ambs, S.7
-
35
-
-
33746218700
-
No association of the MDM2 SNP309 polymorphism with risk of breast or ovarian cancer
-
DOI 10.1016/j.canlet.2005.09.003, PII S0304383505008335
-
Campbell IG, Eccles DM, Choong DY (2006) No association of the MDM2 SNP309 polymorphism with risk of breast or ovarian cancer. Cancer Lett 240:195-197 (Pubitemid 44093819)
-
(2006)
Cancer Letters
, vol.240
, Issue.2
, pp. 195-197
-
-
Campbell, I.G.1
Eccles, D.M.2
Choong, D.Y.H.3
-
36
-
-
33745612767
-
Influence of the MDM2 single nucleotide polymorphism SNP309 on tumour development in BRCA1 mutation carriers
-
DOI 10.1186/1471-2407-6-80
-
Copson ER, White HE, Blaydes JP, Robinson DO, Johnson PW et al (2006) Influence of the MDM2 single nucleotide polymorphism SNP309 on tumour development in BRCA1 mutation carriers. BMC Cancer 6:80 (Pubitemid 43983118)
-
(2006)
BMC Cancer
, vol.6
, pp. 80
-
-
Copson, E.R.1
White, H.E.2
Blaydes, J.P.3
Robinson, D.O.4
Johnson, P.W.5
Eccles, D.M.6
-
37
-
-
33746239400
-
Polymorphisms in the MDM2 promoter and risk of breast cancer: A case-control analysis in a Chinese population
-
DOI 10.1016/j.canlet.2005.09.019, PII S0304383505008670
-
Ma H, Hu Z, Zhai X, Wang S, Wang X et al (2006) Polymorphisms in the MDM2 promoter and risk of breast cancer: a case-control analysis in a Chinese population. Cancer Lett 240:261-267 (Pubitemid 44093826)
-
(2006)
Cancer Letters
, vol.240
, Issue.2
, pp. 261-267
-
-
Ma, H.1
Hu, Z.2
Zhai, X.3
Wang, S.4
Wang, X.5
Qin, J.6
Jin, G.7
Liu, J.8
Wang, X.9
Wei, Q.10
Shen, H.11
-
38
-
-
33845944092
-
Lack of association between the MDM2-SNP309 polymorphism and breast cancer risk
-
Petenkaya A, Bozkurt B, Akilli-Ozturk O, Kaya HS, Gur-Dedeoglu B et al (2006) Lack of association between the MDM2-SNP309 polymorphism and breast cancer risk. Anticancer Res 26:4975-4977 (Pubitemid 46032145)
-
(2006)
Anticancer Research
, vol.26
, Issue.6
, pp. 4975-4977
-
-
Petenkaya, A.1
Bozkurt, B.2
Akilli-Ozturk, O.3
Kaya, H.S.4
Gur-Dedeoglu, B.5
Yulug, I.G.6
-
39
-
-
31544482118
-
The single nucleotide polymorphism IVS1+309 in mouse double minute 2 does not affect risk of familial breast cancer
-
DOI 10.1158/0008-5472.CAN-05-3168
-
Wilkening S, Bermejo JL, Burwinkel B, Klaes R, Bartram CR et al (2006) The single nucleotide polymorphism IVS1 + 309 in mouse double minute 2 does not affect risk of familial breast cancer. Cancer Res 66:646-648 (Pubitemid 43165924)
-
(2006)
Cancer Research
, vol.66
, Issue.2
, pp. 646-648
-
-
Wilkening, S.1
Bermejo, J.L.2
Burwinkel, B.3
Klaes, R.4
Bartram, C.R.5
Meindl, A.6
Bugert, P.7
Schmutzler, R.K.8
Wappenschmidt, B.9
Untch, M.10
Hemminki, K.11
Forsti, A.12
-
40
-
-
34447540243
-
MDM2 SNP309 accelerates familial breast carcinogenesis independently of estrogen signaling
-
DOI 10.1007/s10549-006-9407-5
-
Wasielewski M, Nagel JH, Brekelmans C, Klijn JG, van den Ouweland A et al (2007) MDM2 SNP309 accelerates familial breast carcinogenesis independently of estrogen signaling. Breast Cancer Res Treat 104:153-157 (Pubitemid 47084228)
-
(2007)
Breast Cancer Research and Treatment
, vol.104
, Issue.2
, pp. 153-157
-
-
Wasielewski, M.1
Nagel, J.H.A.2
Brekelmans, C.3
Klijn, J.G.M.4
Van Den Ouweland, A.5
Meijers-Heijboer, H.6
Schutte, M.7
-
41
-
-
34250188802
-
Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk
-
DOI 10.1186/bcr1669
-
Baynes C, Healey CS, Pooley KA, Scollen S, Luben RN et al (2007) Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk. Breast Cancer Res 9:R27 (Pubitemid 350215160)
-
(2007)
Breast Cancer Research
, vol.9
, Issue.2
-
-
Baynes, C.1
Healey, C.S.2
Pooley, K.A.3
Scollen, S.4
Luben, R.N.5
Thompson, D.J.6
Pharoah, P.D.P.7
Easton, D.F.8
Ponder, B.A.J.9
Dunning, A.M.10
Abraham, J.11
Ahmed, S.12
Antoniou, A.13
Benusiglio, P.14
Blows, F.15
Cebrian, A.16
Conroy, D.17
Curzon, B.18
Dew, G.19
Driver, K.20
Field, H.21
Harrington, P.22
Jordan, C.23
Lesueur, F.24
Luccarini, C.25
Mayes, R.26
Munday, H.27
Perkins, B.28
Redman, K.29
Shah, M.30
Tyrer, J.31
Smith, P.32
West, J.33
more..
-
42
-
-
40449093646
-
Implication of BRCA2-26G>A 5′ untranslated region polymorphism in susceptibility to sporadic breast cancer and its modulation by p53 codon 72 Arg>Pro polymorphism
-
17945002 10.1186/bcr1780
-
Gochhait S, Bukhari SI, Bairwa N, Vadhera S, Darvishi K et al (2007) Implication of BRCA2-26G>A 5′ untranslated region polymorphism in susceptibility to sporadic breast cancer and its modulation by p53 codon 72 Arg>Pro polymorphism. Breast Cancer Res 9:R71
-
(2007)
Breast Cancer Res
, vol.9
-
-
Gochhait, S.1
Bukhari, S.I.2
Bairwa, N.3
Vadhera, S.4
Darvishi, K.5
-
43
-
-
33846585408
-
Polymorphism of TP53 codon 72 showed no association with breast cancer in Iranian women
-
DOI 10.1016/j.cancergencyto.2006.09.010, PII S0165460806006121
-
Khadang B, Fattahi MJ, Talei A, Dehaghani AS, Ghaderi A (2007) Polymorphism of TP53 codon 72 showed no association with breast cancer in Iranian women. Cancer Genet Cytogenet 173:38-42 (Pubitemid 46187296)
-
(2007)
Cancer Genetics and Cytogenetics
, vol.173
, Issue.1
, pp. 38-42
-
-
Khadang, B.1
Fattahi, M.J.2
Talei, A.3
Dehaghani, A.S.4
Ghaderi, A.5
-
44
-
-
34548094807
-
Genetic variation in TP53 and risk of breast cancer in a population-based case-control study
-
DOI 10.1093/carcin/bgm097
-
Sprague BL, Trentham-Dietz A, Garcia-Closas M, Newcomb PA, Titus-Ernstoff L et al (2007) Genetic variation in TP53 and risk of breast cancer in a population-based case control study. Carcinogenesis 28:1680-1686 (Pubitemid 47289028)
-
(2007)
Carcinogenesis
, vol.28
, Issue.8
, pp. 1680-1686
-
-
Sprague, B.L.1
Trentham-Dietz, A.2
Garcia-Closas, M.3
Newcomb, P.A.4
Titus-Ernstoff, L.5
Hampton, J.M.6
Chanock, S.J.7
Haines, J.L.8
Egan, K.M.9
-
45
-
-
41849110219
-
MDM2 SNP309 G allele increases risk but the T allele is associated with earlier onset age of sporadic breast cancers in the Chinese population
-
DOI 10.1093/carcin/bgn024
-
Lum SS, Chua HW, Li H, Li WF, Rao N et al (2008) MDM2 SNP309 G allele increases risk but the T allele is associated with earlier onset age of sporadic breast cancers in the Chinese population. Carcinogenesis 29:754-761 (Pubitemid 351494162)
-
(2008)
Carcinogenesis
, vol.29
, Issue.4
, pp. 754-761
-
-
Lum, S.S.1
Chua, H.W.2
Li, H.3
Li, W.-F.4
Rao, N.5
Wei, J.6
Shao, Z.7
Sabapathy, K.8
-
46
-
-
69549145837
-
Association of p53 polymorphisms and its haplotypes with susceptibility of breast cancer
-
18067229 1:CAS:528:DC%2BD1cXhsFWksLzE
-
Zhang W, Jin MJ, Chen K (2007) Association of p53 polymorphisms and its haplotypes with susceptibility of breast cancer. Zhejiang Da Xue Xue Bao Yi Xue Ban 36:561-566
-
(2007)
Zhejiang da Xue Xue Bao Yi Xue Ban
, vol.36
, pp. 561-566
-
-
Zhang, W.1
Jin, M.J.2
Chen, K.3
-
47
-
-
46249094186
-
MDM2 SNP309 does not associate with elevated MDM2 protein expression or breast cancer risk
-
DOI 10.1159/000139135
-
Krekac D, Brozkova K, Knoflickova D, Hrstka R, Muller P et al (2008) MDM2SNP309 does not associate with elevated MDM2 protein expression or breast cancer risk. Oncology 74:84-87 (Pubitemid 351915014)
-
(2008)
Oncology
, vol.74
, Issue.1-2
, pp. 84-87
-
-
Krekac, D.1
Brozkova, K.2
Knoflickova, D.3
Hrstka, R.4
Muller, P.5
Nenutil, R.6
Vojtesek, B.7
-
48
-
-
55349146001
-
MDM2 SNP309 is associated with high grade node positive breast tumours and is in linkage disequilibrium with a novel MDM2 intron 1 polymorphism
-
18828900 10.1186/1471-2407-8-281
-
Paulin FE, O'Neill M, McGregor G, Cassidy A, Ashfield A et al (2008) MDM2 SNP309 is associated with high grade node positive breast tumours and is in linkage disequilibrium with a novel MDM2 intron 1 polymorphism. BMC Cancer 8:281
-
(2008)
BMC Cancer
, vol.8
, pp. 281
-
-
Paulin, F.E.1
O'Neill, M.2
McGregor, G.3
Cassidy, A.4
Ashfield, A.5
-
49
-
-
51649118386
-
MDM2 SNP309 accelerates breast and ovarian carcinogenesis in BRCA1 and BRCA2 carriers of Jewish-Ashkenazi descent
-
18026875 10.1007/s10549-007-9797-z 1:CAS:528:DC%2BD1cXhtV2js7bP
-
Yarden RI, Friedman E, Metsuyanim S, Olender T, Ben-Asher E et al (2008) MDM2 SNP309 accelerates breast and ovarian carcinogenesis in BRCA1 and BRCA2 carriers of Jewish-Ashkenazi descent. Breast Cancer Res Treat 111:497-504
-
(2008)
Breast Cancer Res Treat
, vol.111
, pp. 497-504
-
-
Yarden, R.I.1
Friedman, E.2
Metsuyanim, S.3
Olender, T.4
Ben-Asher, E.5
-
50
-
-
61849084791
-
Results based on 124 cases of breast cancer and 97 controls from Taiwan suggest that the single nucleotide polymorphism (SNP309) in the MDM2 gene promoter is associated with earlier onset and increased risk of breast cancer
-
19144119 10.1186/1471-2407-9-13
-
Sun YF, Leu JD, Chen SM, Lin IF, Lee YJ (2009) Results based on 124 cases of breast cancer and 97 controls from Taiwan suggest that the single nucleotide polymorphism (SNP309) in the MDM2 gene promoter is associated with earlier onset and increased risk of breast cancer. BMC Cancer 9:13
-
(2009)
BMC Cancer
, vol.9
, pp. 13
-
-
Sun, Y.F.1
Leu, J.D.2
Chen, S.M.3
Lin, I.F.4
Lee, Y.J.5
-
51
-
-
73449113685
-
Analysis of p53 gene polymorphisms and protein over-expression in patients with breast cancer
-
19048399 10.1007/s12253-008-9129-6 1:CAS:528:DC%2BD1MXhsFCltrbK
-
Akkiprik M, Sonmez O, Gulluoglu BM, Caglar HB, Kaya H et al (2009) Analysis of p53 gene polymorphisms and protein over-expression in patients with breast cancer. Pathol Oncol Res 15:359-368
-
(2009)
Pathol Oncol Res
, vol.15
, pp. 359-368
-
-
Akkiprik, M.1
Sonmez, O.2
Gulluoglu, B.M.3
Caglar, H.B.4
Kaya, H.5
-
52
-
-
64249101165
-
CCR5 and p53 codon 72 gene polymorphisms: Implications in breast cancer development
-
Aoki MN, da Silva do Amaral Herrera AC, Amarante MK, do Val Carneiro JL, Fungaro MH, et al (2009) CCR5 and p53 codon 72 gene polymorphisms: implications in breast cancer development. Int J Mol Med 23:429-435
-
(2009)
Int J Mol Med
, vol.23
, pp. 429-435
-
-
Aoki, M.N.1
-
53
-
-
67649815036
-
TP53 mutations and Arg72Pro polymorphism in breast cancers
-
19596263 10.1016/j.cancergencyto.2009.03.014 1:CAS:528: DC%2BD1MXosVGnu7k%3D
-
Denisov EV, Cherdyntseva NV, Litvyakov NV, Slonimskaya EM, Malinovskaya EA et al (2009) TP53 mutations and Arg72Pro polymorphism in breast cancers. Cancer Genet Cytogenet 192:93-95
-
(2009)
Cancer Genet Cytogenet
, vol.192
, pp. 93-95
-
-
Denisov, E.V.1
Cherdyntseva, N.V.2
Litvyakov, N.V.3
Slonimskaya, E.M.4
Malinovskaya, E.A.5
-
54
-
-
70449356836
-
Gene polymorphisms in TYMS, MTHFR, p53 and MDR1 as risk factors for breast cancer: A case-control study
-
19885596 10.3892/or-00000584 1:CAS:528:DC%2BD1MXhsFWlu7rL
-
Henriquez-Hernandez LA, Murias-Rosales A, Hernandez Gonzalez A, Cabrera De Leon A, Diaz-Chico BN et al (2009) Gene polymorphisms in TYMS, MTHFR, p53 and MDR1 as risk factors for breast cancer: a case-control study. Oncol Rep 22:1425-1433
-
(2009)
Oncol Rep
, vol.22
, pp. 1425-1433
-
-
Henriquez-Hernandez, L.A.1
Murias-Rosales, A.2
Hernandez Gonzalez, A.3
Cabrera De Leon, A.4
Diaz-Chico, B.N.5
-
55
-
-
78549291388
-
TP53 gene polymorphisms and breast cancer in Croatian women: A pilot study
-
21061796 1:STN:280:DC%2BC3cbmtVaqtA%3D%3D
-
Bisof V, Salihovic MP, Narancic NS, Skaric-Juric T, Jakic-Razumovic J et al (2010) TP53 gene polymorphisms and breast cancer in Croatian women: a pilot study. Eur J Gynaecol Oncol 31:539-544
-
(2010)
Eur J Gynaecol Oncol
, vol.31
, pp. 539-544
-
-
Bisof, V.1
Salihovic, M.P.2
Narancic, N.S.3
Skaric-Juric, T.4
Jakic-Razumovic, J.5
-
56
-
-
77955505936
-
The role of TP53 and p21 gene polymorphisms in breast cancer biology in a well specified and characterized German cohort
-
20127253 10.1007/s00432-010-0788-9 1:CAS:528:DC%2BC3cXpt12lsbo%3D
-
Ebner F, Schremmer-Danninger E, Rehbock J (2010) The role of TP53 and p21 gene polymorphisms in breast cancer biology in a well specified and characterized German cohort. J Cancer Res Clin Oncol 136:1369-1375
-
(2010)
J Cancer Res Clin Oncol
, vol.136
, pp. 1369-1375
-
-
Ebner, F.1
Schremmer-Danninger, E.2
Rehbock, J.3
-
57
-
-
77953085145
-
P53 codon 72 and HER2 codon 655 polymorphisms in Turkish breast cancer patients
-
20380571 10.1089/dna.2009.0995 1:CAS:528:DC%2BC3cXosl2js7w%3D
-
Kara N, Karakus N, Ulusoy AN, Ozaslan C, Gungor B et al (2010) P53 codon 72 and HER2 codon 655 polymorphisms in Turkish breast cancer patients. DNA Cell Biol 29:387-392
-
(2010)
DNA Cell Biol
, vol.29
, pp. 387-392
-
-
Kara, N.1
Karakus, N.2
Ulusoy, A.N.3
Ozaslan, C.4
Gungor, B.5
-
58
-
-
77950371644
-
Haplotype analysis of p53 polymorphisms: Arg72Pro, Ins16bp and G13964C in Tunisian patients with familial or sporadic breast cancer
-
20233677 10.1016/j.canep.2010.02.007 1:CAS:528:DC%2BC3cXnsF2gtbs%3D
-
Trifa F, Karray-Chouayekh S, Mabrouk I, Baccouche S, Khabir A et al (2010) Haplotype analysis of p53 polymorphisms: Arg72Pro, Ins16bp and G13964C in Tunisian patients with familial or sporadic breast cancer. Cancer Epidemiol 34:184-188
-
(2010)
Cancer Epidemiol
, vol.34
, pp. 184-188
-
-
Trifa, F.1
Karray-Chouayekh, S.2
Mabrouk, I.3
Baccouche, S.4
Khabir, A.5
-
59
-
-
0036517472
-
A comprehensive review of genetic association studies
-
DOI 10.1097/00125817-200203000-00002
-
Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K (2002) A comprehensive review of genetic association studies. Genet Med 4:45-61 (Pubitemid 44698579)
-
(2002)
Genetics in Medicine
, vol.4
, Issue.2
, pp. 45-61
-
-
Hirschhorn, J.N.1
Lohmueller, K.2
Byrne, E.3
Hirschhorn, K.4
-
60
-
-
84863003609
-
MDM2 SNP309 polymorphism and breast cancer risk: A meta-analysis
-
Zhao E, Cui D, Yuan L, Lu W (2012) MDM2 SNP309 polymorphism and breast cancer risk: a meta-analysis. Mol Biol Rep 39:3471-3477
-
(2012)
Mol Biol Rep
, vol.39
, pp. 3471-3477
-
-
Zhao, E.1
|